Author

Andrea Rognoni

Interventional Cardiology - Cited by 3,224 - Interventional Cardiology

Biography

Dr. Andrea Rognoni Major University Hospital of Charity from the Department of Cardiology , a interventional Cardiologist. Andrea Rognoni, MD, MSc, PhD, Doctor, Medical Doctor, Coronary Care and Catheterization Laboratory, Hospital "MAggiore della Carità", Novara 28100, Italy
Title
Cited by
Year
Heparin in COVID-19 patients is associated with reduced in-hospital mortality: the multicenter Italian CORIST study
A Di Castelnuovo, S Costanzo, A Antinori, N Berselli, L Blandi, ...Thrombosis and haemostasis 121 (08), 1054-1065, 2021202
90
2021
Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry
E Cerrato, F Giacobbe, G Quadri, F Macaya, M Bianco, R Mori, CA Biolè, ...European Heart Journal 42 (33), 31-3171, 2021202
61
2021
ST-segment elevation myocardial infarction following transcatheter aortic valve replacement
L Faroux, T Lhermusier, F Vincent, L Nombela-Franco, D Tchétché, ...Journal of the American College of Cardiology 77 (17), 2187-2199, 2021202
27
2021
Simple parameters from complete blood count predict in-hospital mortality in COVID-19
M Bellan, D Azzolina, E Hayden, G Gaidano, M Pirisi, A Acquaviva, ...Disease Markers 2021, 1-7, 2021202
27
2021
Contribution of atrial fibrillation to in-hospital mortality in patients with COVID-19
EG Spinoni, M Mennuni, A Rognoni, L Grisafi, C Colombo, V Lio, ...Circulation: Arrhythmia and Electrophysiology 14 (2), e009375, 2021202
25
2021
Catheterization laboratory activity before and during COVID-19 spread: A comparative analysis in Piedmont, Italy, by the Italian Society of Interventional Cardiology (GISE)
G Quadri, A Rognoni, E Cerrato, G Baralis, G Boccuzzi, E Brscic, ...International Journal of Cardiology 323, 288-291, 202
21
2021
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19
MG Mennuni, G Renda, L Grisafi, A Rognoni, C Colombo, V Lio, ...Journal of thrombosis and thrombolysis, 1-9, 212
20
2021
Predictors of mortality and cardiovascular outcome at 6 months after hospitalization for COVID-19
G Renda, F Ricci, EG Spinoni, L Grisafi, D D’ardes, M Mennuni, C Tana, ...Journal of Clinical Medicine (3), 729, 2022202
11
2022
Ticagrelor or clopidogrel after an acute coronary syndrome in the elderly: a propensity score matching analysis from 16,653 patients treated with PCI included in two large …
M Bianco, A Careggio, CA Biole, G Quadri, A Quiros, ...Cardiovascular drugs and therapy 35, 1171-1182, 2021202
10
2021
Safety and efficacy of different antithrombotic strategies after transcatheter aortic valve implantation: a network meta-analysis
EP Navarese, L Grisafi, EG Spinoni, MG Mennuni, A Rognoni, J Ratajczak, ...Thrombosis and Haemostasis 122 (02), 21-225, 2022202
6
2022
Severe valvular heart disease and COVID-19: results from the multicenter international valve disease registry
D Dvir, M Simonato, I Amat-Santos, A Latib, F Kargoli, L Nombela-Franco, ...Structural Heart 5 (4), 424-42, 2021202
6
2021
Impact of stent thickness on clinical outcomes in small vessel and bifurcation lesions: a RAIN-CARDIOGROUP VII sub-study
L Franchin, F Piroli, F D’ascenzo, I Nuñez-Gil, W Wojakowski, Y Imori, ...Journal of Cardiovascular Medicine 22 (1), 20-2, 2021202
5
2021
Safety and efficacy of selective, clopidogrel-based strategies in acute coronary syndrome: a study-level meta-analysis
G Patti, L Grisafi, EG Spinoni, A Rognoni, M MennuniThrombosis and Haemostasis 122 (10), 1732-173, 2022202
4
2022
Low levels of vitamin D and coronary artery disease: Is it time for therapy?
M Verdoia, R Gioscia, M Nardin, A Rognoni, G De LucaKardiologia Polska (Polish Heart Journal) 80 (4), 409-416, 2022202
3
2022
The incidence and impact of in-hospital bleeding in patients with acute coronary syndrome during the COVID-19 pandemic
R Licordari, A Sticchi, F Mancuso, A Caracciolo, S Muscoli, F Iacovelli, ...Journal of Clinical Medicine 11 (10), 2926, 2022202
3
2022
Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI Registry
S Al Raisi, M Protty, S Raposeiras-Roubin, E ABU-ASSI, A ARIZA-SOLÉ, ...Minerva cardiology and angiology 69 (4), 408-416, 010
2
2021
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering
A Di Castelnuovo, A Gialluisi, A Antinori, N Berselli, L Blandi, M Bonaccio, ...Journal of Healthcare Engineering 01, 010
2
2021
Predictors of fractional flow reserve/instantaneous wave-free ratio discordance: impact of tailored diagnostic cut-offs on clinical outcomes of deferred lesions
O De Filippo, G Gallone, F D’Ascenzo, AM Leone, M Mancone, G Quadri, ...Journal of Cardiovascular Medicine 3 (), 106-115, 0
2
2022
Antithrombotic strategy in secondary prevention for high-risk patients with previous acute coronary syndrome: overlap between the PEGASUS eligibility and the COMPASS …
M Millesimo, E Elia, G Marengo, O De Filippo, S Raposeiras-Roubin, ...American Journal of Cardiovascular Drugs 3 (1), 77-87, 030
2
2023
Long-Term Outcomes With Drug-Eluting Balloon for the Treatment of In-Stent Restenosis and De Novo Lesions: The Novara-Biella-Trento (NOBITRE) Registry
M Verdoia, F Zilio, O Viola, MF Brancati, D Fanti, PL Soldà, A Rognoni, ...Angiology 74 (5), 488-495, 2023202
1
2023

Referred From: https://scholar.google.it/citations?user=XUx-8FsAAAAJ&hl=it

Cited by
Citations 3224
h-index 26
i10-index 57
Recommended Journals
Open Access Journals